Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare
From Diligence to Post-Closing: What’s Shifting in 2026 Health Care Transactions
Legal AI in Practice: Firm Governance, Build vs. Buy Decisions, and Vendor Due Diligence — The Good Bot Podcast
From Showroom to Server Room: AI in Auto Finance — Moving the Metal: The Auto Finance Podcast
AI, Algorithms, and Accountability: Unpacking the Colorado AI Act with Senator Rodriguez — Regulatory Oversight Podcast
Navigate the Money Matrix in Our Upcoming Series: Privacy, Security, and AI Explained — The Consumer Finance Podcast
The Briefing: New York Times v. Perplexity AI: Copyright, Hallucinations, and Trademark Risk
No Password Required: Virtual CISO at Trace3 and Roller Derby Penalty Box Visitor
Building a Quantifiable Business Case for AI in Corporate Legal Departments
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 263: Building NC's Innovation Ecosystem with Andrea Conner of First Flight Venture Center
The Privacy Insider Podcast Episode 21: What Businesses Get Wrong About Regulators and How to Fix Privacy Fast
Identifying Good and Bad Use Cases for AI for Law Firms
Moving AI from Hype to Habit
AI's Impact on Litigation
Fintech Focus Podcast | Navigating Growth and Regulation: Lessons From Fintech Leadership
12 Days of Regulatory Insights: Day 9 – The Economic Development Edge — Regulatory Oversight Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 262: Breaking the “Undruggable” Barrier with Marcel Frenkel of Ten63 Therapeutics
Cybersecurity Insights for the Sandwich Generation with Dan Krutoy
12 Days of Regulatory Insights: Day 8 – How State AGs Are Rewriting Social Media Rules — Regulatory Oversight Podcast
We get AI for work™: Is your Tool really AI?
Artificial intelligence was the dominant technology story of 2025, and will remain so in 2026. For better or worse – or, more likely, for both better and worse at the same time – AI is now seeping into every corner of...more
Guess who’s back. Back again. Quantum’s back. Tell your friends. For the third time in three years, the duo of Sen. Todd Young [R-IN] and Sen. Dick Durbin [D-IL] have introduced a bill to reauthorize federal funding in the...more
Last week, the U.S. Court of Appeals for the Seventh Circuit issued a significant decision in Next Payment Solutions, Inc. v. CLEAResult Consulting, Inc., a case that offers important lessons for executives overseeing...more
On November 10, 2025, New York’s Algorithmic Pricing Disclosure Act, N.Y. Gen. Bus. Law § 349-a, took effect. The act survived a First Amendment challenge, becoming the first enacted statute of its kind....more
The global M&A environment is undergoing rapid transformation, driven by evolving regulatory approaches, heightened geopolitical risk, and sector-specific scrutiny. Below, we highlight several critical trends likely to shape...more
Ransomware attacks continue to evolve in sophistication, disrupting operations and commanding the urgent attention of regulators, law enforcement and government agencies....more
Every day, we see the increasing role of technology in our healthcare world. It wasn’t all that long ago that we began the transition to electronic medical records, and portable devices mostly meant BlackBerries....more
On January 16, the U.S. Department of Justice (DOJ) released its annual report on civil fraud recoveries (settlements and judgments) for FY2025, along with a press release highlighting DOJ’s civil enforcement efforts....more
In 1979, an IBM training manual offered a principle that now reads as prophecy: “A computer can never be held accountable, therefore a computer must never make a management decision.” Nearly five decades later, computers—now...more
Under the leadership of Chairman Paul Atkins with a Republican majority on the commission, the Securities and Exchange Commission (SEC) is expected to continue on its trajectory toward regulatory reform that marks a pivot...more
On January 6, 2026, the U.S. Food and Drug Administration (“FDA”) published revised final guidance documents on Clinical Decision Support Software (“Revised CDS Guidance”) and its General Wellness Policy for Low Risk Devices...more
On January 2, 2026, the US Food and Drug Administration (FDA) began accepting statements of interest for its Technology-Enabled Meaningful Patient Outcomes (TEMPO) pilot, a program designed to accelerate access to digital...more
The U.S. Department of Justice (“DOJ”) announced last week that settlements and judgments under the False Claims Act (“FCA”) exceeded $6.8 billion in fiscal year 2025—a record-breaking figure and the highest in a single year...more
The use of AI has been a boon for business owners, because it enables them to analyze large amounts of data quickly and inexpensively, which accelerates their decision-making process without the need to consult others....more
Crypto Custody Provider Announces IPO, Bank Launches Tokenized Deposits - In a recent press release, BitGo Holdings, Inc., a digital asset infrastructure company, “announced the launch of its initial public offering of...more
Since returning to office in January 2025, the Trump administration has taken steps to shift federal AI policy away from the regulatory approach adopted by the Biden administration....more
At the outset of life sciences transactions, there is usually a strong sense of alignment. Founders and investors tend to agree on the importance of discipline, focus, capital efficiency, and long-term value. That was evident...more
The UK Financial Conduct Authority (FCA) has announced the launch of a two-day stablecoin tech-sprint. The sprint, taking place on 4-5 March, will explore the use cases for stablecoins in domestic and international payments,...more
Recently, the U.S. Food and Drug Administration (FDA) issued a guidance document entitled Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices. The guidance outlines the FDA’s current thinking...more
As organizations across the country adapt to an ever-changing digital environment, 2025 brought a wave of important updates in data privacy and cybersecurity at both the federal and state levels. New and amended state laws,...more
When discussing the litigation challenges deepfake technology poses, one typically thinks of difficulties protecting individual privacy rights, complications prosecuting anonymous actors, the lack of law regulating deepfake...more
The EU Cyber Resilience Act (“CRA”) establishes mandatory cybersecurity requirements for most hardware and software products made available on the EU market. While the CRA's date of full application (11 December 2027) is...more
Scrutiny of European Union's dependence on non-European cloud services is intensifying amid geopolitical tensions and rising cyber risk. U.S. hyperscalers control more than 70% of the EU cloud market, while European...more
This past year contained a number of significant developments in litigation involving biologics and biosimilars. The following is a recap of the top three legal developments that we covered on the Big Molecule Watch last...more
What Businesses Need to Know - Contrary to the expectations of many in the privacy field, no new state-level data privacy laws were passed in 2025. As we enter 2026, however, several laws that were passed in 2024, along...more